Identification of genetic variants of lecithin cholesterol acyltransferase in individuals with high HDL‑C levels

Naseri,Mohsen; Hedayati,Mehdi; Daneshpour,Maryam Sadat; Bandarian,Fatemeh; Azizi,Fereidoun

doi:10.3892/mmr.2014.2177

Identification of genetic variants of lecithin cholesterol acyltransferase in individuals with high HDL‑C levels

Authors:
- Mohsen Naseri
- Mehdi Hedayati
- Maryam Sadat Daneshpour
- Fatemeh Bandarian
- Fereidoun Azizi
View Affiliations

Affiliations: Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Published online on: April 24, 2014 https://doi.org/10.3892/mmr.2014.2177
Pages: 496-502

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Among the most common lipid abnormalities, a low level of high‑density lipoprotein‑cholesterol (HDL‑C) is one of the first risk factors identified for coronary heart disease. Lecithin cholesterol acyltransferase (LCAT) has a pivotal role in the formation and maturation of HDL‑C and in reverse cholesterol transport. To identify genetic loci associated with low HDL‑C in a population‑based cohort in Tehran, the promoter, coding regions and exon/intron boundaries of LCAT were amplified and sequenced in consecutive individuals (n=150) who had extremely low or high HDL‑C levels but no other major lipid abnormalities. A total of 14 single‑nucleotide polymorphisms (SNPs) were identified, of which 10 were found to be novel; the L393L, S232T and 16:67977696 C>A polymorphisms have been previously reported in the SNP Database (as rs5923, rs4986970 and rs11860115, respectively) and the non‑synonymous R47M mutation has been reported in the Catalogue of Somatic Mutations in Cancer (COSM972635). Three of the SNPs identified in the present study (position 6,531 in exon 5, position 6,696 in exon 5 and position 5,151 in exon 1) led to an amino acid substitution. The most common variants were L393L (4886C/T) in exon 6 and Q177E, a novel mutation, in exon 5, and the prevalence of the heterozygous genotype of these two SNPs was significantly higher in the low HDL‑C groups. Univariate conditional logistic regression odds ratios (ORs) were nominally significant for Q177E (OR, 5.64; P=0.02; 95% confidence interval, 1.2‑26.2). However, this finding was attenuated following adjustment for confounders. Further studies using a larger sample size may enhance the determination of the role of these SNPs.

View Figures

View References

1	Malaguarnera M, Vacante M, Russo C, et al: Lipoprotein(a) in cardiovascular diseases. Biomed Res Int. 2013:6509892013. View Article : Google Scholar : PubMed/NCBI
2	Azizi F, Rahmani M, Emami H, et al: Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz Praventivmed. 47:408–426. 2002. View Article : Google Scholar : PubMed/NCBI
3	Gordon T, Castelli WP, Hjortland MC, Kannel WB and Dawber TR: High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 62:707–714. 1977. View Article : Google Scholar : PubMed/NCBI
4	Barter P, Gotto AM, LaRosa JC, et al; Treating to New Targets Investigators. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med. 357:1301–1310. 2007. View Article : Google Scholar : PubMed/NCBI
5	Wang X and Paigen B: Genetics of variation in HDL cholesterol in humans and mice. Circ Res. 96:27–42. 2005. View Article : Google Scholar : PubMed/NCBI
6	Boes E, Coassin S, Kollerits B, Heid IM and Kronenberg F: Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review. Exp Gerontol. 44:136–160. 2009. View Article : Google Scholar
7	Holleboom AG, Vergeer M, Hovingh GK, Kastelein JJ and Kuivenhoven JA: The value of HDL genetics. Curr Opin Lipidol. 19:385–394. 2008. View Article : Google Scholar : PubMed/NCBI
8	Weissglas-Volkov D and Pajukanta P: Genetic causes of high and low serum HDL-cholesterol. J Lipid Res. 51:2032–2057. 2010. View Article : Google Scholar : PubMed/NCBI
9	Glomset JA: The mechanism of the plasma cholesterol esterification reaction: plasma fatty acid transferase. Biochim Biophys Acta. 65:128–135. 1962. View Article : Google Scholar : PubMed/NCBI
10	Jonas A: Lecithin cholesterol acyltransferase. Biochim Biophys Acta. 1529:245–256. 2000. View Article : Google Scholar
11	Safran M, Dalah I, Alexander J, et al: GeneCards Version 3: the human gene integrator. Database (Oxford). 2010:baq0202010. View Article : Google Scholar : PubMed/NCBI
12	McLean J, Wion K, Drayna D, Fielding C and Lawn R: Human lecithin-cholesterol acyltransferase gene: complete gene sequence and sites of expression. Nucleic Acids Res. 14:9397–9406. 1986. View Article : Google Scholar : PubMed/NCBI
13	Calabresi L, Simonelli S, Gomaraschi M and Franceschini G: Genetic lecithin: cholesterol acyltransferase deficiency and cardiovascular disease. Atherosclerosis. 222:299–306. 2012. View Article : Google Scholar : PubMed/NCBI
14	Teslovich TM, Musunuru K, Smith AV, et al: Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 466:707–713. 2010. View Article : Google Scholar : PubMed/NCBI
15	Haase CL, Tybjærg-Hansen A, Qayyum AA, Schou J, Nordestgaard BG and Frikke-Schmidt R: LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals. J Clin Endocrinol Metab. 97:E248–E256. 2012. View Article : Google Scholar : PubMed/NCBI
16	Azizi F, Ghanbarian A, Momenan AA, et al: Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 10:52009. View Article : Google Scholar : PubMed/NCBI
17	Azizi F, Raiszadeh F, Salehi P, et al; Tehran Lipid and Glucose Study Group. Determinants of serum HDL-C level in a Tehran urban population: the Tehran Lipid and Glucose Study. Nutr Metab Cardiovasc Dis. 12:80–89. 2002.PubMed/NCBI
18	Warnick GR, Benderson J and Albers JJ: Dextran sulfate-Mg2⁺ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 28:1379–1388. 1982.PubMed/NCBI
19	Friedewald WT, Levy RI and Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18:499–502. 1972.
20	Truett GE, Heeger P, Mynatt RL, Truett AA, Walker JA and Warman ML: Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Biotechniques. 29:52542000.PubMed/NCBI
21	Meyer LR, Zweig AS, Hinrichs AS, Karolchik D, Kuhn RM, Wong M, Sloan CA, Rosenbloom KR, Roe G, Rhead B, Raney BJ, Pohl A, Malladi VS, Li CH, Lee BT, Learned K, Kirkup V, Hsu F, Heitner S, Harte RA, Haeussler M, Guruvadoo L, Goldman M, Giardine BM, Fujita PA, Dreszer TR, Diekhans M, Cline MS, Clawson H, Barber GP, Haussler D and Kent WJ: The UCSC Genome Browser database: extensions and updates 2013. Nucleic Acids Res. 41:D64–D69. 2013. View Article : Google Scholar : PubMed/NCBI
22	Rozen S and Skaletsky H: Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 132:365–386. 2000.PubMed/NCBI
23	Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S and Madden TL: Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics. 13:1342012. View Article : Google Scholar : PubMed/NCBI
24	National Institues of Health (NIH). Database of Single Nucleotide Polymorphisms (dbSNP). NIH; Bethseda, MD: http://www.ncbi.nlm.nih.gov/snp. Accessed May, 2013
25	Flicek P, Ahmed I, Amode MR, et al: Ensembl 2013. Nucleic Acids Res. 41:D48–D55. 2013. View Article : Google Scholar : PubMed/NCBI
26	Altschul SF, Gish W, Miller W, Myers EW and Lipman DJ: Basic local alignment search tool. J Mol Biol. 215:403–410. 1990. View Article : Google Scholar
27	Liu K and Muse SV: PowerMarker: an integrated analysis environment for genetic marker analysis. Bioinformatics. 21:2128–2129. 2005. View Article : Google Scholar : PubMed/NCBI
28	Holleboom AG, Kuivenhoven JA, Peelman F, et al: High prevalence of mutations in LCAT in patients with low HDL cholesterol levels in The Netherlands: identification and characterization of eight novel mutations. Hum Mutat. 32:1290–1298. 2011. View Article : Google Scholar : PubMed/NCBI
29	Stenson PD, Ball E, Howells K, Phillips A, Mort M and Cooper DN: Human Gene Mutation Database: towards a comprehensive central mutation database. J Med Genet. 45:124–126. 2008. View Article : Google Scholar : PubMed/NCBI
30	Forbes SA, Bindal N, Bamford S, et al: COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res. 39:D945–D950. 2011. View Article : Google Scholar : PubMed/NCBI
31	Sim NL, Kumar P, Hu J, Henikoff S, Schneider G and Ng PC: SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 40:W452–W457. 2012. View Article : Google Scholar : PubMed/NCBI
32	Adzhubei IA, Schmidt S, Peshkin L, et al: A method and server for predicting damaging missense mutations. Nat Methods. 7:248–249. 2010. View Article : Google Scholar : PubMed/NCBI
33	Willer CJ, Sanna S, Jackson AU, et al: Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet. 40:161–169. 2008. View Article : Google Scholar : PubMed/NCBI
34	Aulchenko YS, Ripatti S, Lindqvist I, et al; ENGAGE consortium. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet. 41:47–55. 2009. View Article : Google Scholar : PubMed/NCBI
35	Kathiresan S, Willer CJ, Peloso GM, et al: Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet. 41:56–65. 2009. View Article : Google Scholar : PubMed/NCBI
36	Khor CC and Goh DL: Strategies for identifying the genetic basis of dyslipidemia: genome-wide association studies vs. the resequencing of extremes. Curr Opin Lipidol. 21:123–127. 2010. View Article : Google Scholar : PubMed/NCBI
37	Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R and Hobbs HH: Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science. 305:869–872. 2004. View Article : Google Scholar : PubMed/NCBI
38	Kathiresan S, Melander O, Guiducci C, et al: Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet. 40:189–197. 2008. View Article : Google Scholar : PubMed/NCBI
39	Iyengar SK and Elston RC: The genetic basis of complex traits: rare variants or ‘common gene, common disease’? Methods Mol Biol. 376:71–84. 2007.
40	Moriyama K, Sasaki J, Arakawa F, et al: Two novel point mutations in the lecithin:cholesterol acyltransferase (LCAT) gene resulting in LCAT deficiency: LCAT (G873 deletion) and LCAT (Gly344→Ser). J Lipid Res. 36:2329–2343. 1995.PubMed/NCBI
41	Tietjen I, Hovingh GK, Singaraja R, et al: Increased risk of coronary artery disease in Caucasians with extremely low HDL cholesterol due to mutations in ABCA1, APOA1, and LCAT. Biochim Biophys Acta. 1821:416–424. 2012. View Article : Google Scholar : PubMed/NCBI